Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ceribell (CBLL) Other Accumulated Expenses (2023 - 2025)

Historic Other Accumulated Expenses for Ceribell (CBLL) over the last 3 years, with Q3 2025 value amounting to $766000.0.

  • Ceribell's Other Accumulated Expenses rose 2661.16% to $766000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $766000.0, marking a year-over-year increase of 2661.16%. This contributed to the annual value of $609000.0 for FY2024, which is 235.29% up from last year.
  • Ceribell's Other Accumulated Expenses amounted to $766000.0 in Q3 2025, which was up 2661.16% from $785000.0 recorded in Q2 2025.
  • Ceribell's 5-year Other Accumulated Expenses high stood at $841000.0 for Q1 2025, and its period low was $595000.0 during Q4 2023.
  • In the last 3 years, Ceribell's Other Accumulated Expenses had a median value of $687500.0 in 2024 and averaged $700166.7.
  • As far as peak fluctuations go, Ceribell's Other Accumulated Expenses skyrocketed by 235.29% in 2024, and later skyrocketed by 2661.16% in 2025.
  • Over the past 3 years, Ceribell's Other Accumulated Expenses (Quarter) stood at $595000.0 in 2023, then grew by 2.35% to $609000.0 in 2024, then rose by 25.78% to $766000.0 in 2025.
  • Its Other Accumulated Expenses stands at $766000.0 for Q3 2025, versus $785000.0 for Q2 2025 and $841000.0 for Q1 2025.